Answers are grounded in this paper and cite their sources.
Many tumors are refractory to immune checkpoint inhibitors, but their combination with cytotoxics is expected to improve sensitivity. Understanding how and when cytotoxics best re-stimulate tumor immunity could help overcome resistance to immune checkpoint inhibitors.
No takes yet. Share an insight, caveat, or question.
Sicard et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: